---
title: "Evotec and Odyssey collaborate on AI-enabled R&D"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295219756.md"
description: "Evotec and Odyssey have collaborated on AI-enabled R&D to accelerate the discovery of small molecule drug candidates for autoimmune and inflammatory diseases. The partnership combines Evotec's data-driven platforms with Odyssey's biological expertise to identify validated hit series. Evotec may receive milestone payments, though financial details are undisclosed."
datetime: "2026-08-07T09:10:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295219756.md)
  - [en](https://longbridge.com/en/news/295219756.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295219756.md)
---

# Evotec and Odyssey collaborate on AI-enabled R&D

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [ODTX.US](https://longbridge.com/en/quote/ODTX.US.md)
- [EVO.US](https://longbridge.com/en/quote/EVO.US.md)
- [EVT.DE](https://longbridge.com/en/quote/EVT.DE.md)

## Related News & Research

- [EVT: Revenue and profitability declined sharply, with losses deepening and guidance lowered for 2026](https://longbridge.com/en/news/295748980.md)
- [Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases | EVO Stock News](https://longbridge.com/en/news/295063828.md)
- [3 arguments for and against AI watermarks](https://longbridge.com/en/news/296205500.md)
- [Argentum AI Announces $10 Billion+ in Contracted Revenue and Targets 1GW of AI Infrastructure Capacity in 2026](https://longbridge.com/en/news/296261035.md)
- [The AI boom has echoes of Enron — but that might be okay, a tech guru says](https://longbridge.com/en/news/296021200.md)